Home » Topics » Regulatory » Patents

Patents
RSS

Hybridon describes mixed-backbone anti-MDM2 antisense oligonucleotide active in vivo

April 23, 1999

Moxonidine metabolite synthesized by Lilly and assessed in SHR

April 23, 1999

Potent and selective COX-2 inhibitors described in recent patent literature by Novartis

April 23, 1999

Merck & Co. discovers new series with antithrombin effects

April 23, 1999

SmithKline Beecham synthesizes pharmaceutically active integrin receptor antagonists

April 23, 1999

CXCR receptor antagonists in development at SB for chemokine-mediated disorders

April 23, 1999

Malonic acid-based MMP inhibitors with novel binding properties developed at Roche

April 23, 1999

Shiseido provides methods of promoting hair regrowth

April 22, 1999

Inhibitors of PTKs and T-cell activation/proliferation in development at BMS

April 22, 1999

Oxazolidinones useful for resistant Gram-positive infections

April 22, 1999

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...